Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 2;9(3):107.
doi: 10.3390/antibiotics9030107.

Antimicrobial Properties on Non-Antibiotic Drugs in the Era of Increased Bacterial Resistance

Affiliations
Review

Antimicrobial Properties on Non-Antibiotic Drugs in the Era of Increased Bacterial Resistance

Maria Lagadinou et al. Antibiotics (Basel). .

Abstract

In recent years, due to the dramatic increase in and global spread of bacterial resistance to a number of commonly used antibacterial agents, many studies have been directed at investigating drugs whose primary therapeutic purpose is not antimicrobial action. In an era where it is becoming increasingly difficult to find new antimicrobial drugs, it is important to understand these antimicrobial effects and their potential clinical implications. Numerous studies report the antibacterial activity of non-steroidal anti-inflammatory drugs, local anaesthetics, phenothiazines such as chlorpromazine, levomepromazine, promethazine, trifluoperazine, methdilazine and thioridazine, antidepressants, antiplatelets and statins. Several studies have explored a possible protective effect of statins inreducing the morbidity and mortality of many infectious diseases. Various non-antibiotic agents exhibit antimicrobial activity via multiple and different mechanisms of action. Further studies are required in the field to further investigate these antimicrobial properties in different populations. This is of paramount importance in the antimicrobial resistance era, where clinicians have limited therapeutic options to combat problematic infections.

Keywords: NSAIDs; antidepressants; antihistamines; antimicrobial agents; bacteria; non antibiotics; opioids; statins.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this article.

Similar articles

Cited by

References

    1. Steven M.O. Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance. Crit. Care. 2016;20:397. - PMC - PubMed
    1. Silva A.A.d.L., Silva P.M. Non-Antibiotic Compounds: The Activity of the NSAID Diclofenac on Bacteria—A review. Int. J. Curr. Microbiol. Appl. Sci. 2018;7:340–351. doi: 10.20546/ijcmas.2018.712.042. - DOI
    1. Sadik K. Antimicrobial properties of various non-antibiotic drugs against microorganisms. J. Bioanal. Biomed. 2016;8:1120–1124.
    1. Zimmermann P., Curtis N. Antimicrobial effects of antipyretics. Antimicrob. Agents Chemother. 2017;61:e02268-16. doi: 10.1128/AAC.02268-16. - DOI - PMC - PubMed
    1. Dinarello C.A. Anti-inflammatory agents: Present and future. Cell. 2010;140:935–950. doi: 10.1016/j.cell.2010.02.043. - DOI - PMC - PubMed

LinkOut - more resources